AI-generated summary
The authors studied 19 women with facial melasma treated with four sessions of a 675 nm diode laser at one-month intervals. One month after the last session, mMASI scores and Antera 3D camera measurements of melanin and hemoglobin levels showed statistically significant changes, which the authors describe as a safe and efficient approach for darker skin types.
- Participants
- 19
- Who or what was studied
- Nineteen female patients with facial melasma and darker skin types
- Wavelengths
- 675 nm
- Limits stated in the abstract
- The abstract does not describe a control group, and the sample of 19 patients is small.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on journals.sagepub.com.
Record from PubMed, a service of the National Library of Medicine.
Light parameters mentioned
Found in the title and abstract by pattern. They may be incomplete, so check the paper before comparing studies.
- Wavelength
- 675 nm
- Power
- 6 W
How to read a single study: what to check before relying on this kind of research.
Terms in this paper: Laser, Wavelength, Melanin. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.